Age-related macular degeneration is associated with increased proportion of CD56+ T cells in peripheral blood

Ophthalmology

Volumn 120, Issue 11, 2013, Pages 2310-2316

  Faber, Carsten ^a   Singh, Amardeep ^b,c   Krüger Falk, Mads ^b,c   Juel, Helene Bæk ^a   Sørensen, Torben Lykke ^b,c   Nissen, Mogens Holst ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Mental Health Center Glostrup   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; COMPLEMENT FACTOR H; CYTOMEGALOVIRUS ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; LYMPHOCYTE SURFACE MARKER;

ADULT; AGED; ALLELE; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CASE CONTROL STUDY; CD56+ T LYMPHOCYTE; CELL AGING; CELL COMPARTMENTALIZATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; GENETIC RISK; GENOTYPE; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERIPHERAL LYMPHOCYTE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; RETINA MACULA AGE RELATED DEGENERATION; SMOKING; T LYMPHOCYTE;

ADAPTIVE IMMUNITY; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; ANTIGENS, CD56; CASE-CONTROL STUDIES; COMPLEMENT FACTOR H; CYTOMEGALOVIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FLUORESCEIN ANGIOGRAPHY; GENOTYPE; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; T-LYMPHOCYTES; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84887174355     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2013.04.014     Document Type: Article

References (42)

1. M. la Cour, J.F. Kiilgaard, and M.H. Nissen Age-related macular degeneration: epidemiology and optimal treatment Drugs Aging 19 2002 101 133
2. H.R. Coleman, C.C. Chan, F.L. Ferris III, and E.Y. Chew Age-related macular degeneration Lancet 372 2008 1835 1845
3. R. Klein, C.F. Chou, and B.E. Klein Prevalence of age-related macular degeneration in the US population Arch Ophthalmol 129 2011 75 80
4. D.H. Anderson, M.J. Radeke, and N.B. Gallo The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited Prog Retin Eye Res 29 2009 95 112
5. P.F. Zipfel, N. Lauer, and C. Skerka The role of complement in AMD Adv Exp Med Biol 703 2010 9 24
6. H.P. Scholl, P. Charbel Issa, and M. Walier Systemic complement activation in age-related macular degeneration PLoS One [serial online] 3 2008 e2593 Available at http://www.plosone.org/article/info%3Adoi%2F10. 1371%2Fjournal.pone.0002593 Accessed April 7, 2013
7. R. Reynolds, M.E. Hartnett, and J.P. Atkinson Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes Invest Ophthalmol Vis Sci 50 2009 5818 5827
8. D. Smailhodzic, C.C. Klaver, and B.J. Klevering Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration Ophthalmology 119 2012 339 346
9. P. Haas, T. Aggermann, and M. Nagl Implication of CD21, CD35, and CD55 in the pathogenesis of age-related macular degeneration Am J Ophthalmol 152 2011 396 399
10. A. Singh, C. Faber, and M. Falk Altered expression of CD46 and CD59 on leukocytes in neovascular age-related macular degeneration Am J Ophthalmol 154 2012 193 199
11. P.L. Penfold, J.M. Provis, and J.H. Furby Autoantibodies to retinal astrocytes associated with age-related macular degeneration Graefes Arch Clin Exp Ophthalmol 228 1990 270 274
12. N. Patel, M. Ohbayashi, and A.K. Nugent Circulating anti-retinal antibodies as immune markers in age-related macular degeneration Immunology 115 2005 422 430
13. K. Morohoshi, M. Ohbayashi, and N. Patel Identification of anti-retinal antibodies in patients with age-related macular degeneration Exp Mol Pathol 93 2012 193 199
14. H.B. Juel, C. Kaestel, and L.W. Folkersen Retinal pigment epithelial cells upregulate expression of complement factors after co-culture with activated T cells Exp Eye Res 92 2011 180 188
15. D. Aw, A.B. Silva, and D.B. Palmer Immunosenescence: emerging challenges for an ageing population Immunology 120 2007 435 446
16. A.N. Vallejo, R.G. Mueller, and D.L. Hamel Jr. Expansions of NK-like alphabetaT cells with chronologic aging: novel lymphocyte effectors that compensate for functional deficits of conventional NK cells and T cells Ageing Res Rev 10 2011 354 361
17. B.H. Lemster, J.J. Michel, and D.T. Montag Induction of CD56 and TCR-independent activation of T cells with aging J Immunol 180 2008 1979 1990
18. M.J. Pittet, D.E. Speiser, and D. Valmori Cutting edge: cytolytic effector function in human circulating CD8+ T cells closely correlates with CD56 surface expression J Immunol 164 2000 1148 1152
19. S. Chidrawar, N. Khan, and W. Wei Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals Clin Exp Immunol 155 2009 423 432
20. J.M. Seddon, S. Sharma, and R.A. Adelman Evaluation of the clinical age-related maculopathy staging system Ophthalmology 113 2006 260 266
21. R.H. Guymer, L.W. Tao, and J.K. Goh Identification of urinary biomarkers for age-related macular degeneration Invest Ophthalmol Vis Sci 52 2011 4639 4644
22. I. Bergstrom, K. Backteman, and A. Lundberg Persistent accumulation of interferon-gamma-producing CD8+CD56+ T cells in blood from patients with coronary artery disease Atherosclerosis 224 2012 515 520
23. J.J. Michel, C. Turesson, and B. Lemster CD56-expressing T cells that have features of senescence are expanded in rheumatoid arthritis Arthritis Rheum 56 2007 43 57
24. J.K. Ahn, H. Chung, and D.S. Lee CD8brightCD56+ T cells are cytotoxic effectors in patients with active Behcet's uveitis J Immunol 175 2005 6133 6142
25. A. Koreck, A. Suranyi, and B.J. Szony CD3+CD56+ NK T cells are significantly decreased in the peripheral blood of patients with psoriasis Clin Exp Immunol 127 2002 176 182
26. W.X. Li, H.F. Pan, and J.L. Hu Assay of T- and NK-cell subsets and the expression of NKG2A and NKG2D in patients with new-onset systemic lupus erythematosus Clin Rheumatol 29 2010 315 323
27. J. Kelly-Rogers, L. Madrigal-Estebas, T. O'Connor, and D.G. Doherty Activation-induced expression of CD56 by T cells is associated with a reprogramming of cytolytic activity and cytokine secretion profile in vitro Hum Immunol 67 2006 863 873
28. S. Cookson, and D. Reen IL-15 drives neonatal T cells to acquire CD56 and become activated effector cells Blood 102 2003 2195 2197
29. F.M. Mo, A.D. Proia, and W.H. Johnson Interferon gamma-inducible protein-10 (IP-10) and eotaxin as biomarkers in age-related macular degeneration Invest Ophthalmol Vis Sci 51 2010 4226 4236
30. J.M. Seddon, S. George, B. Rosner, and N. Rifai Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers Arch Ophthalmol 123 2005 774 782
31. B. Liu, L. Wei, and C. Meyerle Complement component C5a promotes expression of IL-22 and IL-17 from human T cells and its implication in age-related macular degeneration J Transl Med 9 2011 1 12
32. M.S. Blumenkranz, S.R. Russell, and M.G. Robey Risk factors in age-related maculopathy complicated by choroidal neovascularization Ophthalmology 93 1986 552 558
33. A. Shankar, P. Mitchell, and E. Rochtchina Association between circulating white blood cell count and long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study Am J Epidemiol 165 2007 375 382
34. T. Hong, A.G. Tan, P. Mitchell, and J.J. Wang A review and meta-analysis of the association between C-reactive protein and age-related macular degeneration Surv Ophthalmol 56 2011 184 194
35. P.L. Penfold, M.C. Killingsworth, and S.H. Sarks Senile macular degeneration: the involvement of immunocompetent cells Graefes Arch Clin Exp Ophthalmol 223 1985 69 76
36. R.F. Mullins, M.N. Johnson, and E.A. Faidley Choriocapillaris vascular dropout related to density of drusen in human eyes with early age-related macular degeneration Invest Ophthalmol Vis Sci 52 2011 1606 1612
37. M.K. Ezzat, C.R. Hann, S. Vuk-Pavlovic, and J.S. Pulido Immune cells in the human choroid Br J Ophthalmol 92 2008 976 980
38. V. Tarallo, Y. Hirano, and B.D. Gelfand DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88 Cell 149 2012 847 859
39. S.L. Doyle, M. Campbell, and E. Ozaki NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components Nat Med 18 2012 791 798
40. H.B. Juel, C. Faber, and M.S. Udsen Chemokine expression in retinal pigment epithelial ARPE-19 cells in response to coculture with activated T cells Invest Ophthalmol Vis Sci 53 2012 8472 8480
41. B. Liu, L. Faia, M. Hu, and R.B. Nussenblatt Pro-angiogenic effect of IFNgamma is dependent on the PI3K/mTOR/translational pathway in human retinal pigmented epithelial cells Mol Vis [serial online] 16 2010 184 193 Available at http://www.molvis.org/molvis/v16/a23/ Accessed April 7, 2013
42. R. Sofat, J.P. Casas, and A.R. Webster Complement factor H genetic variant and age-related macular degeneration: effect size, modifiers and relationship to disease subtype Int J Epidemiol 41 2012 250 262